Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

20-Hydroxyecdysone ameliorates metabolic and cardiovascular dysfunction in high-fat-high-fructose-fed ovariectomized rats

Open access

Abstract

Background: Ecdysteroids are polyhydroxylated steroids present in invertebrates and plants. 20-Hydroxyecdysone (20E) is the most common and the main biologically active compound of ecdysteroids. Previous studies have demonstrated anabolic and metabolic effects of 20E in mammals. However, it is unknown whether 20E has a positive effect on all aspects of cardiometabolic syndrome. The aims of this study were to investigate the favorable effect and possible underlying mechanisms of 20E in a rat model of cardiometabolic syndrome (CMS) induced by a high-calorie diet combined with female sex hormone deprivation. Methods: 20E (5 mg/kg, 10 mg/kg, or 20 mg/kg) or pioglitazone (PIO) (10 mg/kg) was intragastrically administered to sham-operated Sprague-Dawley female rats and ovariectomized rats fed a high-fat-high-fructose diet (OHFFD) for 8 weeks. The phenotypic characteristics of CMS, including central adiposity, blood pressure, serum lipid profile, glucose tolerance, insulin action on skeletal muscle glucose transport activity and hepatic protein expression, were determined. Results: Some CMS characteristics were improved by 20E treatment. Rats treated with 20E had lower body weight, abdominal fat accumulation than rats treated with vehicle control without changes in total caloric intake and fat-free mass. OHFFD rats exhibited high blood pressure, but 20E-treated rats maintained normal blood pressure with a lower level of low-density lipoprotein (LDL)-cholesterol. Although 20E showed no positive effect on inducing insulin-mediated glucose transport in the skeletal muscle of OHFFD rats, 20E improved whole body glucose homeostasis. Analysis of protein expression in livers from 20E-treated rats revealed significantly increased expression of pAkt Ser 473, pFOXO1 Ser 256, pAMPKα Thr 172, and FGF21. Conclusion: 20E treatment can alleviate cardiometabolic disorder caused by a high-fat-high-fructose diet and female sex hormone deprivation. In particular, 20E helps improve whole body insulin sensitivity in OHFFD rats, and the mechanisms that underlie this favorable effect are potentially mediated by the activation of AMPK and FGF21. The present study indicates that 20E could be an alternative therapeutic option for the prevention and alleviation of cardiometabolic syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12906-020-02936-1

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Plasma glucose (a) and insulin (b) during an oral glucose tolerance test (OGTT), area under the curve (AUC) for glucose (c) and insulin (d), and glucose-insulin (G-I) index in sham-operated (sham) rats fed a control diet and ovariectomized rats fed a high-fat high-fructose diet (OHFFD) that received 20-hydroxyecdysone (20E) and pioglitazone (PIO). Data for the AUCs were calculated from the glucose and insulin responses. The G-I index was the product of the glucose AUC and insulin AUC for each individual animal. Values are means ±SE for 7–8 animals/group. Data comparisons between groups were performed using one-way ANOVA followed by Tukey’s post hoc analysis. * P < 0.05 vs. OHFFD, ‡ P < 0.05 PIO vs. OHFFD
Fig. 1 Plasma glucose (a) and insulin (b) during an oral glucose tolerance test (OGTT), area under the curve (AUC) for glucose (c) and insulin (d), and glucose-insulin (G-I) index in sham-operated (sham) rats fed a control diet and ovariectomized rats fed a high-fat high-fructose diet (OHFFD) that received 20-hydroxyecdysone (20E) and pioglitazone (PIO). Data for the AUCs were calculated from the glucose and insulin responses. The G-I index was the product of the glucose AUC and insulin AUC for each individual animal. Values are means ±SE for 7–8 animals/group. Data comparisons between groups were performed using one-way ANOVA followed by Tukey’s post hoc analysis. * P < 0.05 vs. OHFFD, ‡ P < 0.05 PIO vs. OHFFDCC BY · PubMed Central
Fig. 2 Effects of 20-hydroxyecdysone (20E; 5 mg/kg, 10 mg/kg, 20 mg/kg) and pioglitazone (PIO) on the levels of the following signaling proteins in the liver: Akt, pAkt Ser473, FOXO1, pFOXO1 Ser256, AMPKα, pAMPKα Thr172, and FGF21. The signaling proteins were measured by immunoblotting and normalized to GAPDH. Data are listed as the fold-change in expression levels relative to the sham control group. Representative bands are shown in the top panel. OHFFD: OVX fed a high-fat high-fructose diet. Values are means ± SEM for 7–8 animals/group. Data comparisons between groups were performed using one-way ANOVA followed by Tukey’s post hoc analysis. *P < 0.05, **P < 0.01, ***P < 0.001 between the indicated groups
Fig. 2 Effects of 20-hydroxyecdysone (20E; 5 mg/kg, 10 mg/kg, 20 mg/kg) and pioglitazone (PIO) on the levels of the following signaling proteins in the liver: Akt, pAkt Ser473, FOXO1, pFOXO1 Ser256, AMPKα, pAMPKα Thr172, and FGF21. The signaling proteins were measured by immunoblotting and normalized to GAPDH. Data are listed as the fold-change in expression levels relative to the sham control group. Representative bands are shown in the top panel. OHFFD: OVX fed a high-fat high-fructose diet. Values are means ± SEM for 7–8 animals/group. Data comparisons between groups were performed using one-way ANOVA followed by Tukey’s post hoc analysis. *P < 0.05, **P < 0.01, ***P < 0.001 between the indicated groupsCC BY · PubMed Central
Fig. 3 Effects of 20-hydeoxyecdysone (20E; 5 mg/kg, 10 mg/kg, 20 mg/kg) and pioglitazone (PIO) on insulin-mediated glucose transport under 2 insulin concentrations: (a) insulin-mediated muscle glucose uptake at 0.2 mU/mL insulin concentration, (b) insulin-mediated muscle glucose uptake at 2 mU/mL insulin. Values are means ± SEM for 3–4 animals/group. Data comparisons between groups were performed using one-way ANOVA followed by Tukey’s post hoc analysis. * P < 0.05 between the indicated groups
Fig. 3 Effects of 20-hydeoxyecdysone (20E; 5 mg/kg, 10 mg/kg, 20 mg/kg) and pioglitazone (PIO) on insulin-mediated glucose transport under 2 insulin concentrations: (a) insulin-mediated muscle glucose uptake at 0.2 mU/mL insulin concentration, (b) insulin-mediated muscle glucose uptake at 2 mU/mL insulin. Values are means ± SEM for 3–4 animals/group. Data comparisons between groups were performed using one-way ANOVA followed by Tukey’s post hoc analysis. * P < 0.05 between the indicated groupsCC BY · PubMed Central
Fig. 4 Proposed mechanisms of 20-hydroxyecdysone action in the liver. 20E increases hepatic function by decreasing hepatic gluconeogenesis via both insulin-dependent downstream PI3K/Akt activation and insulin-independent pathways. 20E activates pAkt Ser473, which is the IRS substrate in the insulin signaling pathway. The activation of Akt caused the inhibition of FOXO1 to translocate into the nucleus through pFOXO1 Ser256. FOXO1 is an important protein that activates PEPCK and G6Pase gene expression. The inhibition of FOXO1 causes a reduction in hepatic gluconeogenesis. 20E also activates AMPKα via pAMPKα Thr172, which causes the suppression of CREB action that normally helps stabilize FOXO1 action inside the nucleus. 20E increases FGF21 expression, which then leads to the activation of pAMPKα Thr172
Fig. 4 Proposed mechanisms of 20-hydroxyecdysone action in the liver. 20E increases hepatic function by decreasing hepatic gluconeogenesis via both insulin-dependent downstream PI3K/Akt activation and insulin-independent pathways. 20E activates pAkt Ser473, which is the IRS substrate in the insulin signaling pathway. The activation of Akt caused the inhibition of FOXO1 to translocate into the nucleus through pFOXO1 Ser256. FOXO1 is an important protein that activates PEPCK and G6Pase gene expression. The inhibition of FOXO1 causes a reduction in hepatic gluconeogenesis. 20E also activates AMPKα via pAMPKα Thr172, which causes the suppression of CREB action that normally helps stabilize FOXO1 action inside the nucleus. 20E increases FGF21 expression, which then leads to the activation of pAMPKα Thr172CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 35

Metadata

Authors
Buniam, J., Chukijrungroat, N., Rattanavichit, Y., Surapongchai, J., Weerachayaphorn, J., Bupha-Intr, T., & Saengsirisuwan, V.
Affiliations
  • Mahidol University (TH)
  • Huachiew Chalermprakiet University (TH)
  • Srinakharinwirot University (TH)
Corresponding author
Saengsirisuwan, Vitoon
Venue
BMC Complementary Medicine and Therapies
Published
2020-05-06
Volume
20
Issue
1
Pages
140-140
ISSN
2662-7671 (ISSN-L)
OpenAlex
W3022084469
Cited by
35
References
44
Citations by year
2026: 6 · 2025: 6 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 11
FWCI
3.39
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Complementary Medicine and Therapies (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Greater South Information System
Funders
  • Royal Golden Jubilee (RGJ) Ph.D. Programme (PHD/4.PE.MU/56/C.1)
  • Mahidol University
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
20-hydroxyecdysone, ecdysteroids, cardiometabolic syndrome, high-fat high-fructose diet, ovariectomy, insulin sensitivity, glucose homeostasis, AMPK, FGF21, FOXO1, Akt signaling, hepatic lipid metabolism, blood pressure, LDL cholesterol, abdominal fat, pioglitazone
MeSH terms
Animals, Blood Pressure, Disease Models, Animal, Ecdysterone, Female, Fructose, Ovariectomy, Rats, Sprague-Dawley, Metabolic Syndrome, Rats, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 20-Hydroxyecdysone ameliorates metabolic and cardiovascular dysfunction in high-fat-high-fructose-fed ovariectomized rats. https://app.cochat.ai/papers/10.1186/s12906-020-02936-1
The paper
Buniam, J., Chukijrungroat, N., Rattanavichit, Y., Surapongchai, J., Weerachayaphorn, J., Bupha-Intr, T., & Saengsirisuwan, V. (2020). 20-Hydroxyecdysone ameliorates metabolic and cardiovascular dysfunction in high-fat-high-fructose-fed ovariectomized rats. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-020-02936-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.